Medical Device | November 26, 2025
India becomes first country to approve STIMULAN Rapid Cure with antifungals
Surgical site infections and antimicrobial resistance remain major challenges globally
Surgical site infections and antimicrobial resistance remain major challenges globally
Reinforcing commitment to ethical and sustainable growth
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
Subscribe To Our Newsletter & Stay Updated
